Neuromuscular Alterations Associated with COVID-19. A Scientific Literature Review

Alteraciones neuromusculares asociadas a la COVID-19. Revisión de la literatura científica


Introduction: The COVID-19 pandemic has brought short, medium, and long-term consequences on the quality of life of those affected. Among the complications are those related to the involvement of the nervous system and the structures involved in body movement, with sequelae that may be transitory and/or definitive, and require rehabilitation.

Objective. Identify the neuromuscular alterations that affect body movement, associated with COVID-19.

Material and methods. A search was made for observational works published in the SCOPUS, PubMed, EBSCO, and Nature databases between January 2020 and June 2022 under the PRISMA methodology, to answer the PICO question: what are the neuromuscular alterations that can potentially affect movement, associated with COVID-19? The established filters were type of study, language, age, availability, publication dates. The MeSH terms were SARS-Cov-2, COVID-19, Long Covid, Motor Activity Neuromuscular Diseases, Neurological Disorders, Guillain-Barré Syndrome, Myelitis Transverse, Stroke, Patient, Peripheral Nervous System Diseases. The methodological quality was evaluated according to STROBE and the level of evidence was established according to CEBM.

Results. In the first search, 645 articles were identified. 637 were discarded by filters, titles, duplicate abstracts, methodological quality, and level of evidence. There were 8 articles selected for the present review in which neuromuscular alterations of central and peripheral origin were identified, such as myalgias, fatigue, polyneuroradiculopathies, CNS inflammation, among others, with clinical manifestations that affect movement.

Conclusion. COVID-19 is a multisystemic disease that can affect the nervous system with symptoms of neuromuscular alterations that compromise body movement.


Download data is not yet available.

Citado por


Eulalia Maria Amador-Rodero
Priscila Mishelle Bartolo Gómez
Fátima del Carmen Carrasco Ferrer
Nancy Paola Ochoa Castillo
Leslie Piedad Montealegre Esmeral
Roberto Carlos Rebolledo Cobos


Delafontaine A, Ditcharles S, Hussein T, Hoffschir M, Plantefève G, Michon D. Physiotherapy and COVID-19: A major public health role to short, medium and long terms in the patient’s rehabilitation process. Kinesitherapie. 2020;20(223):11-18. doi:

Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med [Internet]. 2021;27(4):601–15. doi:

Organización Panamericana de la Salud (OPS). Enfermedad por el Coronavirus (COVID-19) [Internet]. [citado el 5 de julio de 2022]. Disponible en:

Mora D. Impacto de la Variante Ómicron Del Sars-Cov-2 en el mundo. RADA [Internet]. 26 de julio de 2022 [citado 9 de diciembre de 2022];5(1):353-70. Disponible en:

Agarwal A, Pinho M, Raj K, Yu FF, Bathla G, Achilleos M, et al. Neurological emergencies associated with COVID-19: stroke and beyond. Emerg Radiol [Internet]. 2020;27(6):747–54. doi:

Abenza-Abildúa MJ, Ramírez-Prieto MT, Moreno-Zabaleta R, Arenas-Valls N, Salvador-Maya MA, Algarra-Lucas C, et al. Neurological complications in critical patients with COVID-19. Neurología (English Edition) [Internet]. 2020 Nov;35(9):621–7. doi:

Sagarra-Romero L, Viñas-Barros A. COVID-19: Short and Long-Term Effects of Hospitalization on Muscular Weakness in the Elderly. International Journal of Environmental Research and Public Health [Internet]. 2020 Nov 24;17(23):8715. doi:

Masuccio FG, Tipa V, Invernizzi M, Solaro C. Guillain-Barré Syndrome Related and Unrelated to COVID-19: Clinical Follow-Up in the COVID-19 Era. Phys Ther. 2022 Jun 3;102(6):pzac049. doi:

Kirwan, R., McCullough, D., Butler, T. et al. Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss. GeroScience. 2020;42:1547–1578. doi:

Fumery T, Baudar C, Ossemann M, London F. Longitudinally extensive transverse myelitis following acute COVID-19 infection. Mult Scler Relat Disord. 2021 Feb;48:102723. doi:

Shimohata T. Neuro‐COVID‐19. Clinical and Experimental Neuroimmunology [Internet]. 2021 Sep 29;13(1):17–23. doi:

Wong T., Weitzer D. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)—A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina MDPI. 2021;54:418. doi:

Karaarslan F, Güneri FD, Kardeş S. Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months. Clinical Rheumatology [Internet]. 2021 Oct 29;41(1):289–96. doi:

Avenali M, Martinelli D, Todisco M, Canavero I, Valentino F, Micieli G, et al. Clinical and Electrophysiological Outcome Measures of Patients With Post-Infectious Neurological Syndromes Related to COVID-19 Treated With Intensive Neurorehabilitation. Front Neurol. 2021;12. doi:

Mady AF, Abdelfattah RA, Kamel FMM, Abdel Naiem ASM, AbdelGhany WM, Abdelaziz AO. Predictors of long covid 19 syndrome. Egypt J Hosp Med [Internet]. 2021;85(2):3604–8. doi:

Versace V, Sebastianelli L, Ferrazzoli D, Romanello R, Ortelli P, Saltuari L, et al. Intracortical GABAergic dysfunction in patients with fatigue and dysexecutive syndrome after COVID-19. Clin Neurophysiol. 2021;132(5):1138-1143. doi:

Villa D, Ardolino G, Borellini L, Cogiamanian F, Vergari M, Savojardo V, Peyvandi F, Barbieri S. Subclinical myopathic changes in COVID-19. Neurol Sci. 2021;42(10):3973-3979. doi:

Estiri H, Strasser ZH, Brat GA, Semenov YR, Aaron JR, Agapito G, et al. Evolving phenotypes of non-hospitalized patients that indicate long COVID. BMC Medicine [Internet]. 2021 Sep 27;19(1). doi:

Agergaard J, Leth S, Pedersen TH, Harbo T, Blicher JU, Karlsson P, et al. Myopathic changes in patients with long-term fatigue after COVID-19. Clinical Neurophysiology [Internet]. 2021 Aug;132(8):1974–81. doi:

Frontera JA, Yang D, Lewis A, Patel P, Medicherla C, Arena V, et al. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. Journal of the Neurological Sciences [Internet]. 2021 Jul;426:117486. doi:

Abboud H, Abboud FZ, Kharbouch H, Arkha Y, El Abbadi N, El Ouahabi A. COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System. World Neurosurgery [Internet]. 2020 Aug;140:49–53. doi:

Vidale S. Risk Factors, and Clinical and Etiological Characteristics of Ischemic Strokes in COVID-19-Infected Patients: A Systematic Review of Literature. Cerebrovascular Diseases [Internet]. 2021;50(4):371–4. doi:

Haffke M, Freitag H, Rudolf G, Seifert M, Doehner W, Scherbakov N, et al. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS). Journal of Translational Medicine [Internet]. 2022 Mar 22;20(1). doi:

Fotuhi M, Mian A, Meysami S, Raji CA. Neurobiology of COVID-19. Journal of Alzheimer’s Disease [Internet]. 2020 Jun 30;76(1):3–19. Disponible en:

Wirth KJ, Scheibenbogen C. Dyspnea in Post-COVID Syndrome following Mild Acute COVID-19 Infections: Potential Causes and Consequences for a Therapeutic Approach. Medicina [Internet]. 2022 Mar 12;58(3):419. doi:

Harapan BN, Yoo HJ. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). Journal of Neurology [Internet]. 2021 Jan 23;268:3059–3071. doi:

Raveendran AV, Jayadevan R, Sashidharan S. Long COVID: An overview. Diabetes & Metabolic Syndrome: Clinical Research & Reviews [Internet]. 2021 May;15(3):869–75. doi:

Ahmad SJ, Feigen CM, Vazquez JP, Kobets AJ, Altschul DJ. Neurological Sequelae of COVID-19. Journal of Integrative Neuroscience [Internet]. 2022 Apr 6;21(3):77. doi:

Alrubaye R, Bondugula V, Baleguli V, Chofor R. A possible Guillain-Barré syndrome/transverse myelitis overlap syndrome after recent COVID-19. BMJ Case Reports [Internet]. 2022 Feb;15(2):e246967. doi:

Raahimi MM, Kane A, Moore CE, Alareed AW. Late onset of Guillain-Barré syndrome following SARS-CoV-2 infection: part of ‘long COVID-19 syndrome’? BMJ Case Reports [Internet]. 2021 Jan;14(1):e240178. doi:

Vallejo Serna R, Cantor González JF, Arce Gálvez L. Síndrome de Guillain-Barré asociado a COVID-19: diagnóstico, tratamiento y rehabilitación. Neurology Perspectives [Internet]. 2021 Jan;1(1):104–6. doi:

Sundar Shrestha D, Love R. Long COVID Patient Symptoms and its Evaluation and Management. Journal of Nepal Medical Association [Internet]. 2021 Aug 12;59(240). doi:

Bax F, Lettieri C, Marini A, Pellitteri G, Surcinelli A, Valente M, et al. Clinical and neurophysiological characterization of muscular weakness in severe COVID-19. Neurological Sciences [Internet]. 2021 Mar 23;42(6):2173–8. doi:

Tokumasu K, Honda H, Sunada N, Sakurada Y, Matsuda Y, Yamamoto K, et al. Clinical Characteristics of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Diagnosed in Patients with Long COVID. Medicina [Internet]. 2022 Jun 25;58(7):850. Available from:

Chakravarty N, Senthilnathan T, Paiola S, Gyani P, Castillo Cario S, Urena E, et al. Neurological pathophysiology of SARS‐CoV‐2 and pandemic potential RNA viruses: a comparative analysis. FEBS Letters [Internet]. 2021 Nov 22;595(23):2854–71. doi:

Nath A, Smith B. Neurological issues during COVID-19: An overview. Neuroscience Letters [Internet]. 2021 Jan;742:135533. doi:

Almanza-Díaz Y, Carmona-Ferrer B, Sabater-Hernández H. Consideraciones sobre rehabilitación pos-COVID-19. Revista Cubana de Medicina Física y Rehabilitación [revista en Internet]. 2022 [citado 24 Oct 2022];14(3). Disponible en:


Download data is not yet available.